Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection

Wilson B. Chwang, Rajan Jain, Hassan Bagher-Ebadian, Siamak P. Nejad-Davarani, A. S.M. Iskander, Ashley VanSlooten, Lonni Schultz, Ali Syed Arbab, James R. Ewing

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in a rat glioma model, and nested model selection (NMS), to compare estimates of the pharmacokinetic parameters vp, Ktrans, and ve for two different contrast agents (CAs)gadofosveset, which reversibly binds to human serum albumin, and gadopentetate dimeglumine, which does not.

Materials and Methods: DCE-MRI studies were performed on nine Fisher 344 rats inoculated intracerebrally with 9L gliosarcoma cells using both gadofosveset and gadopentetate. The parameters vp, Ktrans, and ve were estimated using NMS.

Results: Ktrans estimates using gadofosveset, compared to gadopentetate, differed in their means (gadofosveset 0.025 ± 0.008 min-1 vs. gadopentetate 0.046 ± 0.011 min-1; P = 0.0039). This difference notwithstanding, the intraclass correlation coefficient (ICC) for the two estimates of Ktrans showed nearly perfect linear dependence (ICC = 0.8479 by Pearson's r). Other estimates, ve (gadofosveset 22.7 ± 4.7% vs. gadopentetate 23.6 ± 5.6%; P = 0.4258) and vp (gadofosveset 1.5 ± 0.5% vs. gadopentetate 1.6 ± 0.4%; P = 0.25), were not different in their means between the two CAs, and there was almost perfect agreement for ve (ICC = 0.8798) and substantial agreement for vp (ICC = 0.7981) between the two CAs.

Conclusion: Estimates of Ktrans were statistically different using gadofosveset and gadopentetate, whereas ve and vp were similar with two CAs. NMS produced robust estimates of pharmacokinetic parameters using DCE-MRI that show promise as important measures of tumor physiology and microenvironment.

Original languageEnglish (US)
Pages (from-to)1223-1229
Number of pages7
JournalJournal of Magnetic Resonance Imaging
Volume40
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

Brain Neoplasms
Contrast Media
Magnetic Resonance Imaging
Pharmacokinetics
Gliosarcoma
Gadolinium DTPA
Tumor Microenvironment
Serum Albumin
Glioma

Keywords

  • Contrast agent
  • DCE-MRI
  • Gadofosveset
  • Gadopentetate

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Chwang, W. B., Jain, R., Bagher-Ebadian, H., Nejad-Davarani, S. P., Iskander, A. S. M., VanSlooten, A., ... Ewing, J. R. (2014). Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection. Journal of Magnetic Resonance Imaging, 40(5), 1223-1229. https://doi.org/10.1002/jmri.24469

Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection. / Chwang, Wilson B.; Jain, Rajan; Bagher-Ebadian, Hassan; Nejad-Davarani, Siamak P.; Iskander, A. S.M.; VanSlooten, Ashley; Schultz, Lonni; Arbab, Ali Syed; Ewing, James R.

In: Journal of Magnetic Resonance Imaging, Vol. 40, No. 5, 01.11.2014, p. 1223-1229.

Research output: Contribution to journalArticle

Chwang, WB, Jain, R, Bagher-Ebadian, H, Nejad-Davarani, SP, Iskander, ASM, VanSlooten, A, Schultz, L, Arbab, AS & Ewing, JR 2014, 'Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection', Journal of Magnetic Resonance Imaging, vol. 40, no. 5, pp. 1223-1229. https://doi.org/10.1002/jmri.24469
Chwang, Wilson B. ; Jain, Rajan ; Bagher-Ebadian, Hassan ; Nejad-Davarani, Siamak P. ; Iskander, A. S.M. ; VanSlooten, Ashley ; Schultz, Lonni ; Arbab, Ali Syed ; Ewing, James R. / Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection. In: Journal of Magnetic Resonance Imaging. 2014 ; Vol. 40, No. 5. pp. 1223-1229.
@article{adc181d2c1af4501b34b03a5fded8be8,
title = "Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection",
abstract = "Purpose: Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in a rat glioma model, and nested model selection (NMS), to compare estimates of the pharmacokinetic parameters vp, Ktrans, and ve for two different contrast agents (CAs)gadofosveset, which reversibly binds to human serum albumin, and gadopentetate dimeglumine, which does not.Materials and Methods: DCE-MRI studies were performed on nine Fisher 344 rats inoculated intracerebrally with 9L gliosarcoma cells using both gadofosveset and gadopentetate. The parameters vp, Ktrans, and ve were estimated using NMS.Results: Ktrans estimates using gadofosveset, compared to gadopentetate, differed in their means (gadofosveset 0.025 ± 0.008 min-1 vs. gadopentetate 0.046 ± 0.011 min-1; P = 0.0039). This difference notwithstanding, the intraclass correlation coefficient (ICC) for the two estimates of Ktrans showed nearly perfect linear dependence (ICC = 0.8479 by Pearson's r). Other estimates, ve (gadofosveset 22.7 ± 4.7{\%} vs. gadopentetate 23.6 ± 5.6{\%}; P = 0.4258) and vp (gadofosveset 1.5 ± 0.5{\%} vs. gadopentetate 1.6 ± 0.4{\%}; P = 0.25), were not different in their means between the two CAs, and there was almost perfect agreement for ve (ICC = 0.8798) and substantial agreement for vp (ICC = 0.7981) between the two CAs.Conclusion: Estimates of Ktrans were statistically different using gadofosveset and gadopentetate, whereas ve and vp were similar with two CAs. NMS produced robust estimates of pharmacokinetic parameters using DCE-MRI that show promise as important measures of tumor physiology and microenvironment.",
keywords = "Contrast agent, DCE-MRI, Gadofosveset, Gadopentetate",
author = "Chwang, {Wilson B.} and Rajan Jain and Hassan Bagher-Ebadian and Nejad-Davarani, {Siamak P.} and Iskander, {A. S.M.} and Ashley VanSlooten and Lonni Schultz and Arbab, {Ali Syed} and Ewing, {James R.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1002/jmri.24469",
language = "English (US)",
volume = "40",
pages = "1223--1229",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection

AU - Chwang, Wilson B.

AU - Jain, Rajan

AU - Bagher-Ebadian, Hassan

AU - Nejad-Davarani, Siamak P.

AU - Iskander, A. S.M.

AU - VanSlooten, Ashley

AU - Schultz, Lonni

AU - Arbab, Ali Syed

AU - Ewing, James R.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Purpose: Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in a rat glioma model, and nested model selection (NMS), to compare estimates of the pharmacokinetic parameters vp, Ktrans, and ve for two different contrast agents (CAs)gadofosveset, which reversibly binds to human serum albumin, and gadopentetate dimeglumine, which does not.Materials and Methods: DCE-MRI studies were performed on nine Fisher 344 rats inoculated intracerebrally with 9L gliosarcoma cells using both gadofosveset and gadopentetate. The parameters vp, Ktrans, and ve were estimated using NMS.Results: Ktrans estimates using gadofosveset, compared to gadopentetate, differed in their means (gadofosveset 0.025 ± 0.008 min-1 vs. gadopentetate 0.046 ± 0.011 min-1; P = 0.0039). This difference notwithstanding, the intraclass correlation coefficient (ICC) for the two estimates of Ktrans showed nearly perfect linear dependence (ICC = 0.8479 by Pearson's r). Other estimates, ve (gadofosveset 22.7 ± 4.7% vs. gadopentetate 23.6 ± 5.6%; P = 0.4258) and vp (gadofosveset 1.5 ± 0.5% vs. gadopentetate 1.6 ± 0.4%; P = 0.25), were not different in their means between the two CAs, and there was almost perfect agreement for ve (ICC = 0.8798) and substantial agreement for vp (ICC = 0.7981) between the two CAs.Conclusion: Estimates of Ktrans were statistically different using gadofosveset and gadopentetate, whereas ve and vp were similar with two CAs. NMS produced robust estimates of pharmacokinetic parameters using DCE-MRI that show promise as important measures of tumor physiology and microenvironment.

AB - Purpose: Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in a rat glioma model, and nested model selection (NMS), to compare estimates of the pharmacokinetic parameters vp, Ktrans, and ve for two different contrast agents (CAs)gadofosveset, which reversibly binds to human serum albumin, and gadopentetate dimeglumine, which does not.Materials and Methods: DCE-MRI studies were performed on nine Fisher 344 rats inoculated intracerebrally with 9L gliosarcoma cells using both gadofosveset and gadopentetate. The parameters vp, Ktrans, and ve were estimated using NMS.Results: Ktrans estimates using gadofosveset, compared to gadopentetate, differed in their means (gadofosveset 0.025 ± 0.008 min-1 vs. gadopentetate 0.046 ± 0.011 min-1; P = 0.0039). This difference notwithstanding, the intraclass correlation coefficient (ICC) for the two estimates of Ktrans showed nearly perfect linear dependence (ICC = 0.8479 by Pearson's r). Other estimates, ve (gadofosveset 22.7 ± 4.7% vs. gadopentetate 23.6 ± 5.6%; P = 0.4258) and vp (gadofosveset 1.5 ± 0.5% vs. gadopentetate 1.6 ± 0.4%; P = 0.25), were not different in their means between the two CAs, and there was almost perfect agreement for ve (ICC = 0.8798) and substantial agreement for vp (ICC = 0.7981) between the two CAs.Conclusion: Estimates of Ktrans were statistically different using gadofosveset and gadopentetate, whereas ve and vp were similar with two CAs. NMS produced robust estimates of pharmacokinetic parameters using DCE-MRI that show promise as important measures of tumor physiology and microenvironment.

KW - Contrast agent

KW - DCE-MRI

KW - Gadofosveset

KW - Gadopentetate

UR - http://www.scopus.com/inward/record.url?scp=84913613760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913613760&partnerID=8YFLogxK

U2 - 10.1002/jmri.24469

DO - 10.1002/jmri.24469

M3 - Article

C2 - 24421265

AN - SCOPUS:84913613760

VL - 40

SP - 1223

EP - 1229

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 5

ER -